Focus Group Study on the Feeling Tone Mindfulness Course
Launched by THE UNIVERSITY OF HONG KONG · Sep 29, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a four-week program called the Feeling Tone Mindfulness Course, which aims to help people manage feelings of depression, anxiety, and stress, while also improving overall well-being. The researchers want to understand how well participants accept and benefit from the course by gathering their feedback in focus group discussions.
To participate, you need to be at least 18 years old and able to speak and understand Cantonese and written Chinese. You should also have access to online tools like Zoom for meetings and online surveys. Importantly, participants must have already completed the mindfulness course. While the study is not yet recruiting participants, it offers a chance for individuals looking to enhance their mental health through mindfulness practices to share their experiences and insights.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18 or above
- • Speak and understand Cantonese as well as written Chinese to a level where the participant can fully take part in the focus group session without the need for translation support
- • Have means to access online teleconferencing meeting software (e.g., Zoom), online surveys (to give their informed consent and to schedule a focus group session), online materials, and Short Message Service (SMS) or WhatsApp messenger.
- • Participants who have completed the four-week feeling tone mindfulness course
- Exclusion Criteria:
- • N/A
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Hoi Chun Lok, MSocSc(CP)
Principal Investigator
Department of Psychology, The University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported